Scott Warwick was chosen for the role following a nationwide search
$190 million and 12 years in the making
Cost analysis favorably compares proton APBI with radiation WBI
Research funded by feds to save lives offers faster, cheaper testing
Releases alpha particles that destroy tumors, spare healthy surrounding tissue
U.S. PT market to exceed $1 billion by 2022
Staff will bring together 70 years' net worth of proton experience
New study will compare IMRT to IMPT for head and neck cancer
Scientist emeritus makes his case
Sera Prognostics adds new member to board of directors
Measuring appropriate use and untapped potential with two new studies
Patients reluctantly in the dark when it comes to understanding imaging
Unique approaches to lowering dose and spreading the right information
New research supports the modifications
Could lead to genetic screenings to identify humans who should not be imaged with radiation
Last BEIR report on effects of low-dose exposure issued over 10 years ago
Treatment can significantly reduce dose to heart and lung tissue
Lifting the "curse" of not seeing for proton treatment
Third-parties can create own products, update medical equipment